These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 5756173)
41. [Study of the therapeutic effect of a cardioactive glycoside extracted from scilla (proscillaridin A), by means of polygraphic investigations]. Facci M Minerva Med; 1966 May; 57(43 Suppl):1978-82. PubMed ID: 5943255 [No Abstract] [Full Text] [Related]
42. [Mental disorders among patients of the acute poisoning department]. Jezierska A Pol Tyg Lek; 1980 Jul; 35(29):1095-7. PubMed ID: 7433186 [No Abstract] [Full Text] [Related]
43. [Attempts at discontinuing cardiac glycosides in general practice]. Hügel A; Hügel I Z Arztl Fortbild (Jena); 1989; 83(9):471-2. PubMed ID: 2750222 [No Abstract] [Full Text] [Related]
44. [Clinical action of a new cardioactive glycoside: proscillaridin A]. Facci M Minerva Med; 1967 Dec; 58(96):4276-86. PubMed ID: 6083289 [No Abstract] [Full Text] [Related]
45. Is accutane really dangerous? Med Lett Drugs Ther; 2002 Sep; 44(1139):82. PubMed ID: 12322695 [No Abstract] [Full Text] [Related]
46. [On the clinical action of a new derivative of maritime squill (proscillaridinA)]. De Benedetti F; Rizzo F Minerva Med; 1967 Dec; 58(96):4267-76. PubMed ID: 6083288 [No Abstract] [Full Text] [Related]
47. [Subjective symptoms of intoxication in patients treated with cardiac glycosides]. Surbat R Med Arh; 1977; 31(2):61-7. PubMed ID: 904370 [No Abstract] [Full Text] [Related]
48. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration]. Rosini E; Petacchi R Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292 [No Abstract] [Full Text] [Related]
49. [Proscillardin A in the treatment of cardiocirculatory insufficiency. Clinco-experimental contribution]. Bellomo A; Strobbia R; Lalloni R; Dalzotto U Minerva Med; 1967 Dec; 58(96):4246-62. PubMed ID: 6083286 [No Abstract] [Full Text] [Related]
50. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies]. Pagliara R Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717 [No Abstract] [Full Text] [Related]
51. [On the circulatory effect of the coronary dilator PETN]. Tilsner V Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489 [No Abstract] [Full Text] [Related]
52. [Action of oral proscillaridin treatment in various forms of heart insufficiency]. Muth HW; Weyer H Med Welt; 1965 Dec; 51():2883-6. PubMed ID: 5884860 [No Abstract] [Full Text] [Related]
53. [Research on a new cardioactive glycoside in clinical practice: proscillaridin A]. Meschino S; Meoni S Minerva Med; 1966 May; 57(43 Suppl):2000-4. PubMed ID: 5943259 [No Abstract] [Full Text] [Related]
55. [Psychiatric symptoms related to interferon treatment for chronic hepatitis]. Hosoda S; Kohno M; Kumada H Seishin Shinkeigaku Zasshi; 2003; 105(6):768-86. PubMed ID: 14560593 [TBL] [Abstract][Full Text] [Related]
56. [Contribution to the quantitative and qual-itative study on the glycoside proscillaridin]. Wülfing von der Heyden D Med Welt; 1969 Mar; 13():738-43. PubMed ID: 5784356 [No Abstract] [Full Text] [Related]
57. [Clonidine in opiate withdrawal. II. Potential side-effects]. Keup W MMW Munch Med Wochenschr; 1982 Feb; 124(7):153-5. PubMed ID: 6801495 [No Abstract] [Full Text] [Related]
58. [The use of a new cardioactive glucoside: Proscillaridin A, in the treatment of cardiopathy in the aged]. Massoni G G Gerontol; 1967 Apr; 15(4):565-72. PubMed ID: 5605011 [No Abstract] [Full Text] [Related]